Literature DB >> 22698791

A disintegrin and metalloproteases: molecular scissors in angiogenesis, inflammation and atherosclerosis.

Emiel P C van der Vorst1, Anke A Keijbeck, Menno P J de Winther, Marjo M P C Donners.   

Abstract

A disintegrin and metalloproteases (ADAMs) are enzymes that cleave (shed) the extracellular domains of various cell surface molecules, e.g. adhesion molecules, cytokine/chemokine and growth factor receptors, thereby releasing soluble molecules that can exert agonistic or antagonistic functions or serve as biomarkers. By functioning as such molecular scissors, ADAM proteases have been implicated in various diseases, e.g. cancer, and their role in cardiovascular diseases is now emerging. This review will focus on the role of ADAM proteases in molecular mechanisms of angiogenesis and inflammation in relation to atherosclerosis. Besides a concise overview of the current state and recent advances of this research area, we will discuss key questions about redundancy, specificity and regulation of ADAM proteases and emphasize the importance of confirmation of in vitro findings in in vivo models.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698791     DOI: 10.1016/j.atherosclerosis.2012.04.023

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

Review 1.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

2.  Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization.

Authors:  Monika Hartmann; Liseth M Parra; Anne Ruschel; Christina Lindner; Helen Morrison; Andreas Herrlich; Peter Herrlich
Journal:  J Biol Chem       Date:  2015-04-29       Impact factor: 5.157

Review 3.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

4.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

5.  N-Tertaining a New Signaling Paradigm for the Cardiomyocyte β 1 -Adrenergic Receptor.

Authors:  Susan F Steinberg
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

Review 6.  Cut loose and run: The complex role of ADAM proteases during neural crest cell development.

Authors:  Dominique Alfandari; Lisa A Taneyhill
Journal:  Genesis       Date:  2018-02-24       Impact factor: 2.487

7.  β1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β1-adrenergic receptors.

Authors:  Jing Zhu; Susan F Steinberg
Journal:  J Mol Cell Cardiol       Date:  2021-02-06       Impact factor: 5.000

8.  Glomerular Endothelial Cells Are the Coordinator in the Development of Diabetic Nephropathy.

Authors:  Tingting Li; Kaiyuan Shen; Jiawei Li; Susan W S Leung; Tongyu Zhu; Yi Shi
Journal:  Front Med (Lausanne)       Date:  2021-06-18

Review 9.  The epidermal growth factor receptor and its ligands in cardiovascular disease.

Authors:  Nader Makki; Kristina W Thiel; Francis J Miller
Journal:  Int J Mol Sci       Date:  2013-10-15       Impact factor: 5.923

Review 10.  Targeting GPVI as a novel antithrombotic strategy.

Authors:  Robert K Andrews; Jane F Arthur; Elizabeth E Gardiner
Journal:  J Blood Med       Date:  2014-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.